
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biogen Inc. (BIIB) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biogen Inc. (BIIB)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">29</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">9</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">9</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">-0.04</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1d0fd8c8b5dc7475dbcf06900281d80b3055f6042a4d103cbbc0ae2b9ec6af81" target="_blank" rel="noopener noreferrer">Biogen : to Participate in the TD Cowen 45th Annual Health Care Conference</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-24</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Cambridge, MA, - - Biogen Inc. announced today that Christopher A. Viehbacher, President and Chief Executive Officer, will participate in a fireside chat during the TD Cowen 45th Annual Health Care......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1d3c79e7fa899df042431640936a056b7abd7ca2d5321b125a671fda53957b2e" target="_blank" rel="noopener noreferrer">Biogen Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c147bb3682f8801342414e0c14009394d6ffbd5f6cd03234c4043a82013f96c7" target="_blank" rel="noopener noreferrer">Ionis Pharmaceuticals Reports Strong Q4 Earnings After Recent FDA Approval</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-19</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.38
                                </span>
                            </div>
                            <div class="article-summary">Ionis Pharmaceuticals beats Q4 earnings, eyes sHTG market with TRYNGOLZA. Strong pipeline and cash position make it a must-watch. Read more on IONS stock here....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c06c3437be5573b8b80b4a3b0cf24dc5901feba75524204d1702df7a2be24c5e" target="_blank" rel="noopener noreferrer">Biogen, Stoke Therapeutics Set Dravet Syndrome Collaboration</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-18</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen, Stoke Therapeutics Set Dravet Syndrome Collaboration...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3aa0b6211cbcd1908b35ad13e3417fb53a5530db15b1674f8402daf1192a5a67" target="_blank" rel="noopener noreferrer">Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-18</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9158e1247f9718d3e8a1093f7e7de1e04d5e89f133d52c6d4879748505ed7f82" target="_blank" rel="noopener noreferrer">Parnassus Value Equity Fund Q4 And 2024 Annual Investment Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-17</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.44
                                </span>
                            </div>
                            <div class="article-summary">The Parnassus Value Equity Fund returned -1.48% (net) for Q4 2024, outperforming the Russell 1000 Value Indexâs -1.98%. Click here to read the full commentary. ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1908ae121981d02b68da5bc073bf916f1b609732896126c3f308191022cd89a" target="_blank" rel="noopener noreferrer">Biogen Q4 Earnings Review: Why I'm Calling Time On This 'Powder Puff' Pharma</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-15</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Biogenâs disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to declining drug franchises....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5c8cb51b89d35d82bfac778baac9b340cf1cf6f4b33510fa420f0d27a69ad040" target="_blank" rel="noopener noreferrer">Market darlings Robinhood, Reddit and Applovin deliver earnings after the close</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.61
                                </span>
                            </div>
                            <div class="article-summary">Market darlings Robinhood, Reddit and Applovin deliver earnings after the close...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=74fb724b94cbf46ae8ce8b598adc0a911db20a0a556db730fafd169a09ac37f8" target="_blank" rel="noopener noreferrer">Biogen 4Q Revenue Tops Wall Street's Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biogen 4Q Revenue Tops Wall Street's Estimates...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=500bd2f58266f3903bcb26f7f8355118cceb46eb6e359af9313536b24ec2caa6" target="_blank" rel="noopener noreferrer">Biogen Inc. 2024 Q4 - Results - Earnings Call Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The following slide deck was published by Biogen Inc....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8752eff66bc6053f9eb730fe92ef615715b504a682d16602e15a86204ee73628" target="_blank" rel="noopener noreferrer">Biogen’s stock slides on soft guidance and a decline in sales of MS drugs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Biogen’s stock slides on soft guidance and a decline in sales of MS drugs...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=898e23d9211dc87201b7ef9b481a371167f52c2d9333c2a5c708d0ed7b66a2e9" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Q4 2024 Earnings Call Transcript</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher -......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=df7b6b16222a4d9df19fe1603c4ca0739629f88a56fca2424eac04f033d1671e" target="_blank" rel="noopener noreferrer">Wall Street Lunch: Boom Goes The CPI</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">The January Consumer Price Index jumped +0.5% in January, accelerating from +0.4% in December...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=27aa8f31be954227ceeb4a88abf938e8df1d51c04d7d47582a08cbb4bb59620f" target="_blank" rel="noopener noreferrer">Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-12</span>
                                <span>DowJones</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e2069e25fb042bac679e3572ea14e0ace4d38f9caf58d083080726f0c4e39887" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Tuesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-11</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Tuesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=04a6cc6384e5428124ad5d3acbfa978d0323850881a377f00981946ec584cad3" target="_blank" rel="noopener noreferrer">ClearBridge Global Value Improvers Strategy Q4 2024 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-10</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.28
                                </span>
                            </div>
                            <div class="article-summary">The ClearBridge Global Value Improvers Strategy outperformed its MSCI World Value benchmark during Q4 2024. Click here to read the full commentary. ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c53d6da218d3e0dff3d23c29cc62d30faa6affbd96ab775dd070ff30d050a218" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Thursday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-06</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Thursday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1bd73486fe2530c637cdb2ee223448c7c0496f7832338f5284749043c92391e" target="_blank" rel="noopener noreferrer">Biogen Inc. - Update on Regulatory Review of Lecanemab for Early Alzheimer's disease in the European Union</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-03</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">TOKYO, CAMBRIDGE - Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD and......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dd232797cab74e9f47846033f3ef2bcd217d452b7625ce532b41ee4678c298a1" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Monday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-02-03</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Monday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=16337370353012a609428accee101e02c9700d6be142ce7a8632e288ec4aad7f" target="_blank" rel="noopener noreferrer">Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-31</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 -- Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=25be6f3ff452a4f919263352b4ebc3f3420fa75955bf6764b6394a1b4ba101e1" target="_blank" rel="noopener noreferrer">Europe to review safety data for Eisai-Biogen Alzheimer's drug</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-31</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's Alzheimer's drug Leqembi, the agency said on Friday. The safety......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9a2ba48d0d9614920393fab5480e1f4ffdc1cc1312bab8d6b6f387f25ef77711" target="_blank" rel="noopener noreferrer">Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-31</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a0ad8335447271826b5dcfc3a3b756e34dbfee705c861cb2927e624b6e09d62b" target="_blank" rel="noopener noreferrer">Biogen, Eisai : EC Asks CHMP to Take Another Look at Leqembi</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-31</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">By Colin Kellaher Biogen and Eisai have hit another bump in their quest to win European regulatory approval of their Alzheimer's drug Leqembi. The companies on Friday said the European......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2c4b8cf33f22ffa2ca48dbdb870cd9d0a2fb867801f77d9e74553628e13018fd" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Friday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-31</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Friday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=807a50ea0c6a2372c4ebe63ea205fd0ad2ae4f349be31f3f83a4905ea9273fad" target="_blank" rel="noopener noreferrer">Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">By Colin Kellaher Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=62c224d0f341c6cfd59f56d913d96ecabf0807d685077728da9b847335e88e22" target="_blank" rel="noopener noreferrer">Sage rejects Biogen's takeover offer, to explore strategic alternatives</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen and added that its board of directors has initiated a process to explore strategic.....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7f1a9040f9399865b55776489be150745a519c828f1bf6ecb79bfa659100f033" target="_blank" rel="noopener noreferrer">Sage Rejects Biogen Bid, Launches Review of Alternatives</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-27</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Sage Rejects Biogen Bid, Launches Review of Alternatives...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dd1eea152db726341e8670ee837ab49fe99a9071df680f014f1433952abf4b4f" target="_blank" rel="noopener noreferrer">Eisai Co., Ltd. - FDA Approves LEQEMBI IV Maintenance Dosing for the Treatment of Early Alzheimer s disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.74
                                </span>
                            </div>
                            <div class="article-summary">TOKYO, CAMBRIDGE - Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration has approved the Supplemental Biologics License Application for once every four weeks......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=31b2a31324650d91dad6ea79e7874201488ebdff3c52d9e8f95fb8e69d076d0c" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Monday when compared to competitors despite daily gains</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-01-27</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.77
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Monday when compared to competitors despite daily gains...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        